Portal de Periódicos da CAPES

Carbapenem-resistant Acinetobacter baumannii : epidemiology, surveillance and management

2013; Taylor & Francis; Volume: 11; Issue: 4 Linguagem: Inglês

10.1586/eri.13.14

1744-8336

Jason M. Pogue, Tal Mann, Katie E. Barber, Keith S. Kaye,

Antibiotics Pharmacokinetics and Efficacy

Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A. baumannii are on the rise and are slowly becoming a routine phenotype for this organism. This review focuses on infection control strategies for identification and control of A. baumannii, as well the available therapeutic options.